Abstract

The purpose of this study was to analyze the differences in coping strategies employed by liver transplant recipients and their family members according to patient posttraumatic growth. Two matched groups of 214 liver transplant recipients and 214 family members were selected. The Posttraumatic Growth Inventory and Brief COPE were used. The most relevant results were: (1) Interactive effects in active coping, support (instrumental and emotional) and acceptance strategies, which were all used more by patients with higher growth levels, while their family members showed no differences in use of these strategies by patient growth level. Furthermore, while a low level of patient growth did not mark differences between them and their caregivers, a high level did, patients employing more active coping and support (instrumental and emotional), (2) In both groups a high level of patient growth was associated with more use of positive reframing and denial than a low one, and (3) Self-blame was employed by patients more than by their caregivers. It was concluded that a high level of posttraumatic growth in liver transplant recipients is associated with more use of healthy coping strategies, basically active coping, instrumental support, and emotional support.

Highlights

  • Liver transplantation is a therapeutic option which increases the patient’s quality of life, not up to normative data (Fernández-Jiménez et al, 2012; Pérez-San-Gregorio et al, 2013)

  • Medium posttraumatic growth showed a difference in instrumental support (p < 0.001, d = 0.56, medium effect size), as this strategy was more used by patients than by their caregivers (Table 3)

  • The use of those strategies by family members did not vary with patient posttraumatic growth level

Read more

Summary

Introduction

Liver transplantation is a therapeutic option which increases the patient’s quality of life, not up to normative data (Fernández-Jiménez et al, 2012; Pérez-San-Gregorio et al, 2013). Such surgery forms part of a very stressful process which must be faced by the patients and their families. Immunosuppressant treatment has secondary effects with negative repercussions on the patient’s quality of life (Grinyó et al, 2012). This can be coped with in different ways, from strategies facilitating adaptation to a new medical condition (for example, acceptance or positive reframing) to other strategies which would impede

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call